MedPath

Combination of Artificial Intelligence and Mucosal Exposure Device to Enhance Colorectal Neoplasia Detection

Not Applicable
Recruiting
Conditions
Colorectal Neoplasms
Adenoma
Colorectal Cancer
Interventions
Device: ENDOCUFF
Registration Number
NCT05414448
Lead Sponsor
Chinese University of Hong Kong
Brief Summary

The investigators hypothesize that the combined use of CADe system (ENDOAID) and mucosal exposure device (Endocuff Vision®) would improve the adenoma detection rate when compared to CADe system alone.

Detailed Description

High polyp miss rates were reported in standard colonoscopies. As a result, a significant proportion of interval CRC was attributed to the missed lesions during index colonoscopy. Risk factors of missed lesions included proximal location, serrate or flat morphology, poor bowel preparation, short withdrawal time and endoscopist experience.

To overcome this pitfall, various methods were developed to improve adenoma detection rate (ADR), including distal attachment devices. Among the mucosal exposure devices, Endocuff Vision® was shown to be superior than conventional colonoscopies.

Recently, artificial intelligence and automatic computer-aided polyp detection (CADe) systems have developed rapidly and revolutionized the medical field. Nevertheless, there was a potential limitation of 'blind spot' if the endoscopist failed to expose the colonic mucosa adequately leading to missed lesions. To date, no available data or ongoing clinical trial was reported regarding the combined use of CADe and mucosal exposure devices. It may enhance the performance of CADe and provide a novel definitive solution to this unaddressed yet important clinical problem.

In this prospective parallel randomized controlled trial, we aim to evaluate the impact of combined use of a new CADe system (ENDOAID) and mucosal exposure device (Endocuff Vision®) on colorectal neoplasia detection.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1726
Inclusion Criteria
  1. Aged 45-85 years old;
  2. They require elective colonoscopy for colorectal cancer screening, polyp surveillance, or investigation of symptoms such as anemia or altered bowel habit;
  3. Written informed consent obtained.
Read More
Exclusion Criteria
  1. Contraindication to colonoscopy (e.g. intestinal obstruction or perforation)
  2. Contraindication or conditions precluding polyp resection (e.g. active gastrointestinal bleeding, uninterrupted anticoagulation or dual antiplatelets)
  3. Staged procedure for polypectomy or biopsy of known unresected lesions
  4. Previous surgical resection of colon
  5. Personal history of colorectal cancer
  6. Personal history of familial polyposis syndrome
  7. Personal history of inflammatory bowel disease
  8. Advanced comorbid conditions (defined as American Society of Anesthesiologists grade 4 or above)
  9. Pregnancy
  10. Unable to obtain informed consent
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ENDOAID with ENDOCUFFENDOCUFFCADe system and mucosal exposure device (ENDOCUFF) will be used during withdrawal phase of colonoscopy.
Primary Outcome Measures
NameTimeMethod
ADRDuring the colonoscopy

adenoma detection rate

Secondary Outcome Measures
NameTimeMethod
ADR for adenomas of different colonic segmentsDuring the colonoscopy

caecum, ascending colon, hepatic flexure, transverse colon, splenic flexure, descending colon, sigmoid colon, rectum

Non-neoplastic resection rateDuring the colonoscopy

defined as absence of adenoma or SSL or cancer within resected specimen

False positive rateDuring the colonoscopy

defined as computer artifacts due to colonic mucosal wall or bowel content lasting for \>2 seconds

Withdrawal timeDuring the colonoscopy

excluding interventions

Total procedural timeDuring the colonoscopy

Total procedural time

Caecal intubation timeDuring the colonoscopy

Caecal intubation time

ADR for adenomas of different sizesDuring the colonoscopy

\<5mm, 5-10mm, \>10mm

Mean number of adenomas per colonoscopyDuring the colonoscopy

Mean number of adenomas per colonoscopy

Sessile serrated lesion (SSL) detection rateDuring the colonoscopy

Sessile serrated lesion (SSL) detection rate

Advanced adenoma detection rateDuring the colonoscopy

Advanced adenoma detection rate

Polyp detection rateDuring the colonoscopy

Polyp detection rate

Trial Locations

Locations (1)

Prince of Wales Hospital

🇭🇰

Shatin, Hong Kong Island, Hong Kong

© Copyright 2025. All Rights Reserved by MedPath